Dietary Adjustments to Reduce Nausea on GLP-1 Therapy Eating smaller, more frequent meals (46 per day instead of 3 large ones) reduces the volume your stomach must process at once, directly lowering nausea risk
For patients whose primary goal is glycemic control, the choice still depends on the full clinical picture, comorbidities, and tolerability
Weir said while the FLOW data were very positive for semaglutide, the high price of the medication may be a barrier to access for some patients
Patients should inspect their tirzepatide pen before injection, following the specific inspection instructions provided in the medication's Instructions for Use
GLP-1 MDL Update: Court May Soon Define Scope of Warning and Preemption Motion Practice The GLP-1 products liability MDL in the Eastern District of Pennsylvania is approaching a significant procedural inflection point
the available data derive overwhelmingly from cell-culture and animal models